2024 Laboratory Reimbursement Trends and What to Expect in 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Two of the biggest merger and acquisition-related deals that came down in May involved BioMérieux and Sema4
Senate committee members propose a modified version of legislation allowing the FDA to continue to regulate LDTs on a risk-tiered basis.
Companies will explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.
Companies are using the lessons learned from COVID-19 to get out of the box quickly in developing test kits for monkeypox.
Most diagnostics companies experienced modest, flat, or negative top-line revenue growth rates in the first quarter of 2022.
What happens when lab personnel’s OSHA rights to access illness and injury records seemingly clash with HIPAA privacy laws?
New OIG Advisory Opinion offers valuable insight into where the agency draws the line on free genetic tests.
Of this month’s four Labs in Court cases, three involved kickbacks resulting in widely varying penalties.
A briefing of the current requirements you can use to avoid billing and coding errors at your own lab or pathology practice.
A newly finalized local coverage determination from MAC Palmetto GBA sets out coverage criteria for two applications of these tests.